Clinical Trial Update: Observational Study of Patients With Diabetes Using Levemir® FlexPen®

View source ↗

Summary

This document reports an observational study of patients with diabetes using Levemir FlexPen (insulin detemir) to assess real-world usage and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir FlexPen (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED